Inventor profile of:

John A. Gaudette

City:

Poway, California

Country:

United States

Published Applications:

17

Last publication date:

2020-06-25

Top Assignees for applications by John A. Gaudette

The entities that hold a legal rights for patent applications filed by inventor Gaudette John A.:

Recent patent applications by Gaudette John A.

John A. Gaudette from Poway, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-06-25
US20200199064A1
Chemistry; metallurgy

Cationic lipids for therapeutic agent delivery formulations

#2 | 2020-03-19
US20200085957A1
Human necessities

Lipids for therapeutic agent delivery formulations

#3 | 2018-10-18
US20180297938A1
Chemistry; metallurgy

Compounds for targeting drug delivery and enhancing siRNA activity

#4 | 2018-07-26
US20180208547A1
Chemistry; metallurgy

Cationic lipids for therapeutic agent delivery formulations

#5 | 2017-03-23
US20170081663A1
Chemistry; metallurgy

Retinoid-lipid drug carrier

#6 | 2017-01-05
US20170001950A1
Chemistry; metallurgy

Compounds for targeting drug delivery and enhancing siRNA activity

#7 | 2017-01-05
US20170000893A1
Human necessities

Compounds for targeting drug delivery and enhancing siRNA activity

#8 | 2016-05-19
US20160137593A1
Chemistry; metallurgy

Cationic lipids for therapeutic agent delivery formulations

#9 | 2016-03-17
US20160074514A1
Human necessities

Lipids for therapeutic agent delivery formulations

#10 | 2016-01-21
US20160015656A2
Human necessities

COMPOSITION FOR REGENERATING NORMAL TISSUE FROM FIBROTIC TISSUE

#11 | 2014-10-02
US20140294934A1
Human necessities

Cationic lipids for therapeutic agent delivery formulations

#12 | 2013-12-12
US20130330401A1
Human necessities

Lipids for therapeutic agent delivery formulations

#13 | 2013-08-15
US20130210744A1
Human necessities

TARGETING AGENT FOR CANCER CELL OR CANCER-ASSOCIATED FIBROBLAST

#14 | 2013-07-04
US20130171240A1
Human necessities

DRUG CARRIER AND DRUG CARRIER KIT FOR INHIBITING FIBROSIS

#15 | 2013-07-04
US20130171127A1
Human necessities

COMPOSITION FOR REGENERATING NORMAL TISSUE FROM FIBROTIC TISSUE

#16 | 2013-01-24
US20130022665A1
Chemistry; metallurgy

Cationic lipids for therapeutic agent delivery formulations

#17 | 2013-01-17
US20130017249A1
Chemistry; metallurgy

Compounds for targeting drug delivery and enhancing siRNA activity

InventorID:

40373 ⎘